Evidence map›Paper›PMID 32123584›Full record

ArticleCell death discovery2020

Delivery of phosphatidylethanolamine blunts stress in hepatoma cells exposed to elevated palmitate by targeting the endoplasmic reticulum.

Marcus Trentzsch, Eugene Nyamugenda, Tiffany K Miles, Haven Griffin, Susan Russell, Brian Koss, Kimberly A Cooney, Kevin D Phelan, Alan J Tackett, Srividhya Iyer and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Marcus Trentzsch *1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR USA.
Eugene Nyamugenda *1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR USA.
Tiffany K Miles *1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR USA.
Haven Griffin1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR USA.
Susan Russell1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR USA.
Brian Koss1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR USA.
Kimberly A Cooney1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR USA.
Kevin D Phelan2Department of Neurobiology & Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, AR USA.
Alan J Tackett1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR USA.
Srividhya Iyer3Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, Little Rock, AR USA.ORCID 0000-0002-8953-373X
Gunnar Boysen4Department of Environmental and Occupational Health, University of Arkansas for Medical Sciences, Little Rock, AR USA.
Giulia Baldini1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR USA.
University of Arkansas for Medical Sciences · US

Funding

Zosuquidar trihydrochloride for acute myeloid leukemia &refractory anemiaM01RR000080 · NCRR · UNIVERSITY HOSPITALS OF CLEVELAND · PI DEARBORN, DORR GELLATLY · 1985 to 2007
$22.2M
Expanding Translational Research in ArkansasUL1TR003107 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI JAMES, LAURA P · 2019 to 2023
$21.6M
Arkansas Center for Clinical and Translational ResearchUL1TR000039 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$10.0M
The University of Arkansas for Medical Sciences Initiative for Maximizing Student Development ProgramR25GM083247 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI MCGEHEE, ROBERT E, THOMAS, BILLY R · 2009 to 2023
$5.4M
Lipid Stress and MC4R - RevisionR01DK102206 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI BALDINI, GIULIA · 2014 to 2018
$1.8M
Systems Pharmacology and Toxicology Training ProgramT32GM106999 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI PRATHER, PAUL L · 2013 to 2022
$1.4M
NCATS NIH HHS UL1 TR000039NCATS NIH HHS UL1 TR003107NCRR NIH HHS M01 RR000080NIDDK NIH HHS R01 DK102206NIGMS NIH HHS R25 GM083247NIGMS NIH HHS T32 GM106999
6 · The paper itself

Abstract

Genetic obesity increases in liver phosphatidylcholine (PC)/phosphatidylethanolamine (PE) ratio, inducing endoplasmic reticulum (ER) stress without concomitant increase of ER chaperones. Here, it is found that exposing mice to a palm oil-based high fat (HF) diet induced obesity, loss of liver PE, and loss of the ER chaperone Grp78/BiP in pericentral hepatocytes. In Hepa1-6 cells treated with elevated concentration of palmitate to model lipid stress, Grp78/BiP mRNA was increased, indicating onset of stress-induced Unfolded Protein Response (UPR), but Grp78/BiP protein abundance was nevertheless decreased. Exposure to elevated palmitate also induced in hepatoma cells decreased membrane glycosylation, nuclear translocation of pro-apoptotic C/EBP-homologous-protein-10 (CHOP), expansion of ER-derived quality control compartment (ERQC), loss of mitochondrial membrane potential (MMP), and decreased oxidative phosphorylation. When PE was delivered to Hepa1-6 cells exposed to elevated palmitate, effects by elevated palmitate to decrease Grp78/BiP protein abundance and suppress membrane glycosylation were blunted. Delivery of PE to Hepa1-6 cells treated with elevated palmitate also blunted expansion of ERQC, decreased nuclear translocation of CHOP and lowered abundance of reactive oxygen species (ROS). Instead, delivery of the chemical chaperone 4-phenyl-butyrate (PBA) to Hepa1-6 cells treated with elevated palmitate, while increasing abundance of Grp78/BiP protein and restoring membrane glycosylation, also increased ERQC, expression and nuclear translocation of CHOP, non-mitochondrial oxygen consumption, and generation of ROS. Data indicate that delivery of PE to hepatoma cells under lipid stress recovers cell function by targeting the secretory pathway and by blunting pro-apoptotic branches of the UPR.

Indexed as

ApoptosisCell death

Identifiers

PMID32123584
PMCPMC7028721
OpenAlexW3009939116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.